Paule Opolon
Centre National de la Recherche Scientifique(FR)Inserm(FR)Université Paris-Saclay(FR)Institut Gustave Roussy(FR)
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Virus-based gene therapy research, Cancer, Hypoxia, and Metabolism, RNA Interference and Gene Delivery, CAR-T cell therapy research
Most-Cited Works
- → Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors(2017)5,249 cited
- → Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota(2015)3,336 cited
- → The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide(2013)1,967 cited
- → TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis(2011)888 cited
- → Tumor Ablation with Irreversible Electroporation(2007)471 cited
- → AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations(2017)450 cited